John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 20,000 shares at $57.58 ($1.2M) on 2026-08-11, disclosed to the SEC on 2026-08-13.
Open-market sale of $1.2M TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.58 | 17,000 | $979K | 84.7% |
| 2 | $58.73 | 3,000 | $176K | 15.3% |
| Total | $57.75 avg | 20,000 | $1.2M | 100% |
| Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |
| TXG | SELL | 2021-11-18 | $1.6M | — | Filing → |